Volume | 1 114 551 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 0,1939 | Bas Haut |
|||||
Minimum Bas | 0,1701 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Qualigen Therapeutics Inc | QLGN | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,1881 | 0,1701 | 0,1939 | 0,1803 | 0,193 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
1 395 | 1 114 551 | US$ 0,1810702 | US$ 201 812 | - | 0,1449 - 1,26 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
00:36:50 | formt | 1 500 | US$ 0,1854 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
2,84M | 6,31M | - | 0 | -13,42M | -2,13 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Qualigen Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
30/5/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
30/5/2024 | 22:00 | GlobeNewswire Inc. | Qualigen Therapeutics, Inc. Received Nasdaq Notice of a.. |
14/5/2024 | 22:05 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
04/5/2024 | 02:59 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
16/4/2024 | 13:00 | GlobeNewswire Inc. | Marizyme Enters Into Co-Development Agreement With Qualigen.. |
10/4/2024 | 14:00 | GlobeNewswire Inc. | Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors.. |
09/4/2024 | 14:00 | GlobeNewswire Inc. | Qualigen Therapeutics Announces Poster Featuring Positive.. |
27/2/2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
22/2/2024 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report |
07/12/2023 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
22/11/2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
14/11/2023 | 22:30 | GlobeNewswire Inc. | Qualigen Therapeutics Provides Corporate Update for Third.. |
Forum Action Qualigen Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Qualigen Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,2062 | 0,243 | 0,1661 | 0,1976995 | 15 512 666 | -0,0208 | -10,09% |
1 mois | 0,296 | 0,33 | 0,1449 | 0,2007671 | 3 553 736 | -0,1106 | -37,36% |
3 mois | 0,406 | 0,445 | 0,1449 | 0,2069505 | 1 232 301 | -0,2206 | -54,33% |
6 mois | 0,58 | 0,61 | 0,1449 | 0,2198991 | 607 489 | -0,3946 | -68,03% |
1 an | 0,9269 | 1,26 | 0,1449 | 0,2453515 | 311 140 | -0,7415 | -80,00% |
3 ans | 21,20 | 31,20 | 0,1449 | 14,54 | 1 059 571 | -21,01 | -99,13% |
5 ans | 72,50 | 79,00 | 0,1449 | 23,22 | 1 141 173 | -72,31 | -99,74% |